Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 3
2021 2
2022 2
2023 1
2024 1
2025 4
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 29713631

15 results

Results by year

Filters applied: . Clear all
Page 1
Trehalose alleviates nephropathy in focal segmental glomerulosclerosis via the upregulation of the WT-1/EZH2 pathway.
Al-Asmakh M, Riyami MA, Al Marbuii M, Al Sinawi S, Al-Badi S, Ismaili FA, AlKharusi A, Zadjali R, Alharthi Z, Al Mashrafi S, Al Breiki R, Al-Hashmi S, Al Lawati A, Kassab A, Zadjali F. Al-Asmakh M, et al. Front Pharmacol. 2025 Nov 6;16:1706617. doi: 10.3389/fphar.2025.1706617. eCollection 2025. Front Pharmacol. 2025. PMID: 41282610 Free PMC article.
Population Risk Predictors of Major Adverse Kidney Events in Patients with Focal Segmental Glomerulosclerosis from the CURE-CKD Registry.
Nicholas SB, Kornowske LM, Jones CR, Daratha KB, Alicic RZ, Reynolds CL, Neumiller JJ, Bensink ME, Gong W, Norris KC, Tuttle KR. Nicholas SB, et al. Res Sq [Preprint]. 2025 May 6:rs.3.rs-5844460. doi: 10.21203/rs.3.rs-5844460/v1. Res Sq. 2025. Update in: BMC Nephrol. 2025 Jul 19;26(1):403. doi: 10.1186/s12882-025-04334-6. PMID: 40386414 Free PMC article. Updated. Preprint.
Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial Design.
Walsh L, Reilly JF, Cornwall C, Gaich GA, Gipson DS, Heerspink HJL, Johnson L, Trachtman H, Tuttle KR, Farag YMK, Padmanabhan K, Pan-Zhou XR, Woodworth JR, Czerwiec FS. Walsh L, et al. Kidney Int Rep. 2021 Jul 23;6(10):2575-2584. doi: 10.1016/j.ekir.2021.07.006. eCollection 2021 Oct. Kidney Int Rep. 2021. PMID: 34622097 Free PMC article.
15 results